hepatitis B

The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: ‘The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa’ by Lemoine et al
Alexander J Stockdale, Richard Odame Phillips, Anna Maria Geretti

Gut May 2016, 65 (5) 882-884; DOI: 10.1136/gutjnl-2015-311133
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Perrine Martin, Clarisse Dubois, Emilie Jacquier, Sarah Dion, Maryline Mancini-Bourgine, Ophélie Godon, Roland Kratzer, Karine Lelu-Santolaria, Alexei Evlachev, Jean-François Meritet, Yasmin Schlesinger, Dominique Villeval, Jean-Marc Strub, Alain Van Dorsselaer, Jean-Baptiste Marchand, Michel Geist, Renée Brandely, Annie Findeli, Houda Boukhebza, Thierry Menguy, Nathalie Silvestre, Marie-Louise Michel, Geneviève Inchauspé

Gut Dec 2015, 64 (12) 1961-1971; DOI: 10.1136/gutjnl-2014-308041
Comprehensive screening of chymotrypsin C (CTRC) gene in tropical calcific pancreatitis identifies novel variants
Sumit Paliwal, Seema Bhaskar, K Radha Mani, D Nageshwar Reddy, G Venkat Rao, Shivaram Prasad Singh, Varghese Thomas, Giriraj Ratan Chandak

Gut Nov 2013, 62 (11) 1602-1606; DOI: 10.1136/gutjnl-2012-302448
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal

Gut Dec 2015, 64 (12) 1972-1984; DOI: 10.1136/gutjnl-2015-309809
TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication
Daniel W H Ho, Lo K Chan, Yung T Chiu, Iris M J Xu, Ronnie T P Poon, Tan T Cheung, Chung N Tang, Victor W L Tang, Irene L O Lo, Polly W Y Lam, Derek T W Yau, Miao X Li, Chun M Wong, Irene O L Ng

Gut Aug 2017, 66 (8) 1496-1506; DOI: 10.1136/gutjnl-2016-312734
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim, Young-Suk Lim, Jihyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Gut Aug 2014, 63 (8) 1325-1332; DOI: 10.1136/gutjnl-2013-305517
Peginterferon therapy for chronic hepatitis B: one size fits all?
Henry Lik-Yuen Chan

Gut Feb 2013, 62 (2) 185-187; DOI: 10.1136/gutjnl-2012-303291
Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study
Tien Huey Lim, Edward Gane, Chris Moyes, Barry Borman, Chris Cunningham

Gut Jun 2015, 64 (6) 966-972; DOI: 10.1136/gutjnl-2013-306247
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia
Yusuke Shimakawa, Maud Lemoine, Harr Freeya Njai, Christian Bottomley, Gibril Ndow, Robert D Goldin, Abdoulie Jatta, Adam Jeng-Barry, Rita Wegmuller, Sophie E Moore, Ignatius Baldeh, Makie Taal, Umberto D'Alessandro, Hilton Whittle, Ramou Njie, Mark Thursz, Maimuna Mendy

Gut Dec 2016, 65 (12) 2007-2016; DOI: 10.1136/gutjnl-2015-309892
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Pietro Lampertico, Mauro Viganò, Giovan Giuseppe Di Costanzo, Evangelista Sagnelli, Massimo Fasano, Vito Di Marco, Sara Boninsegna, Patrizia Farci, Silvia Fargion, Tiziana Giuberti, Claudio Iannacone, Loredana Regep, Benedetta Massetto, Floriana Facchetti, Massimo Colombo, on behalf of the PegBeLiver Study Group

Gut Feb 2013, 62 (2) 290-298; DOI: 10.1136/gutjnl-2011-301430

Main menu

hepatitis B

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

hepatitis B

Pages